Literature DB >> 15363545

Catechol-O-methyltransferase low activity genotype (COMTLL) is associated with low levels of COMT protein in human hepatocytes.

Anne E Sullivan Doyle1, Julie E Goodman, Paul M Silber, James D Yager.   

Abstract

A single nucleotide polymorphism in the COMT (catechol-O-methyltransferase) gene that alters the amino acid sequence at codon 108 of S-COMT from val to met (val108met polymorphism) has been associated with a number of diseases and neuropsychiatric disorders. Several studies have shown that the met108 allele (COMTL) is associated with three to four-fold lower levels of COMT activity, compared to the val108 allele (COMTH), in extracts of human erythrocytes, liver and kidney tissue. We hypothesized that the differences in COMT activity observed in these studies were due to differing levels of COMT protein in cells and tissues with varying COMT genotypes. In order to address this, we obtained hepatocytes from 31 Caucasian female donors and determined their COMT genotype, COMT activity and COMT protein levels. We found that both cytosolic COMT activity and cytosolic COMT protein levels are lower in hepatocytes from COMTLL individuals, and that COMT activity levels correlate with COMT protein levels. Therefore, lower COMT activity seen in tissues and cells with the COMTLL genotype is likely due to lower COMT protein levels compared with tissues and cells from COMTHH individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15363545     DOI: 10.1016/j.canlet.2004.06.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

Review 1.  Genetic diversity and new therapeutic concepts.

Authors:  Barkur S Shastry
Journal:  J Hum Genet       Date:  2005-07-23       Impact factor: 3.172

2.  Catechol-O-methyltransferase: effects of the val108met polymorphism on protein turnover in human cells.

Authors:  Anne E Doyle; James D Yager
Journal:  Biochim Biophys Acta       Date:  2007-10-16

3.  The catechol-O-methyltransferase inhibitor, tolcapone, increases the bioavailability of unmethylated (-)-epigallocatechin-3-gallate in mice.

Authors:  Sarah C Forester; Joshua D Lambert
Journal:  J Funct Foods       Date:  2015-08-01       Impact factor: 4.451

4.  Decreased catecholamine degradation associates with shock and kidney injury after cardiac surgery.

Authors:  Anja Haase-Fielitz; Michael Haase; Rinaldo Bellomo; Gavin Lambert; George Matalanis; David Story; Laurie Doolan; Brian Buxton; Geoff Gutteridge; Friedrich C Luft; Wolf-Hagen Schunck; Duska Dragun
Journal:  J Am Soc Nephrol       Date:  2009-04-30       Impact factor: 10.121

5.  A hotspot of inactivation: The A22S and V108M polymorphisms individually destabilize the active site structure of catechol O-methyltransferase.

Authors:  Karen Rutherford; Valerie Daggett
Journal:  Biochemistry       Date:  2009-07-14       Impact factor: 3.162

6.  Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.

Authors:  James D Yager
Journal:  Drug Discov Today Dis Mech       Date:  2012-06-01

Review 7.  Genetic Biomarkers of Metabolic Detoxification for Personalized Lifestyle Medicine.

Authors:  Lucia Aronica; Jose M Ordovas; Andrey Volkov; Joseph J Lamb; Peter Michael Stone; Deanna Minich; Michelle Leary; Monique Class; Dina Metti; Ilona A Larson; Nikhat Contractor; Brent Eck; Jeffrey S Bland
Journal:  Nutrients       Date:  2022-02-11       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.